HDAC-IN-36 is an orally active HDAC (histone deacetylase) inhibitor with an IC50 value of 11.68 nM for HDAC6. HDAC-IN-36 induces apoptosis, autophagy and inhibits migration. HDAC-IN-36 exhibits antitumor and antimetastatic effects and can be used to study breast cancer. HDAC-IN-36 exhibits antitumor and antimetastatic effects and can be used to study breast cancer.
Molecular Weight:
537.65
CAS Number:
[2482992-54-9]
Formula:
C29H39N5O5
Target:
Others|||HDAC|||Apoptosis|||Autophagy
T63791
* VAT and and shipping costs not included. Errors and price changes excepted
